Dr. Zini received his Medical degree and completed his urologic training at McGill University in Montreal. He then completed a fellowship in male infertility at the New York Hospital-Cornell Medical Centre and The Population Council in New York. Dr. Zini is Professor of Urology at McGill University and Head of the Division of Urology at St. Mary’s Hospital in Montreal. Dr. Zini is also the Director of the Andrology Fellowship Program at McGill University. He has supervised over 25 medical residents and over 15 clinical fellows. Dr. Zini’s main expertise is in the area of male infertility. His clinical research interests include varicoceles, sperm retrieval techniques and the role of semen oxidants and antioxidants in male infertility. He has focused his basic research activity on the study of human sperm DNA damage and the impact of this damage on male fertility potential. Dr. Zini has published over 150 papers, 15 book chapters and has co-edited 2 books on the role of sperm DNA damage in male infertility. Dr. Zini has served on several national and international committees for the development of guidelines on the evaluation and treatment of male infertility and associated urological disorders. In 2010, he co-founded a nutraceuticals company that develops supplements for male infertility and urological disorders.
B.Sc., McGill University, 1982-1985; MDCM, McGill University, 1985-1989
English, French
Department of Surgery-Urology, McGill University, 1989-1994;
Fellowship, Infertility, Department of Surgery-Urology, Cornell University, 1994-1996
6900 Décarie Boulevard, Suite M-265
Montréal, Québec
H3X 2T8
A breath of modern air blows through the ELNA network! Following the overhaul of ELNA Medical’s brand image, it’s now the turn
Montreal-based ELNA Medical Group (“ELNA”), Canada’s largest integrated network of medical clinics, announced today its acquisition of Physimed Health Group (“Physimed”), a pioneer in private and public medicine and leader in the realm of corporate medicine in Quebec.
Prostate cancer is the most common cancer among men in Canada and Quebec. It mainly affects men over the age of 50,
ELNA, announced today the acquisition of Neurothérapie Montréal, a leading Canadian multidisciplinary centre specializing in mental health and brain-based disorders
An estimated 30% of Canadian adults are at high risk for having or developing sleep apnea. As a condition in which disturbed
ELNA, announced today the acquisition of Neurothérapie Montréal, a leading Canadian multidisciplinary centre specializing in mental health and brain-based disorders
Attention deficit disorder with or without hyperactivity (ADHD) affects between 5% and 8% of children. ADHD can affect different aspects of their
More than 40,000 Quebecers are diagnosed with a Sexually Transmitted Infection (STI) every year. Find out how you can contract an STI,
Montreal-based ELNA Medical Group, Canada’s largest integrated network of medical clinics, announced today the appointment of Patrick Ifergan as Chief Financial Officer (CFO).
Children who have been out in the sun a lot and have had serious sunburns (painful, blistering skin) will be at greater
